ADVERTISEMENT

Coronavirus vaccine: The contenders, the potential controversy

The Journal of Family Practice. 2020 September;69(7):audio | 10.12788/jfp.0050
September 1, 2020|Covid ICYMI
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker does contract work for the Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices, helping them assess the effectiveness and safety of vaccines.

With COVID-19 cases in the United States exceeding 5 million, much hope is being placed on the development of a vaccine. Dr. Campos-Outcalt describes the 5 vaccine candidates currently in rapid development through Operation Warp Speed, a private/federal initiative to substantially shorten vaccine development time. He also explains the safeguards in place to reassure the public that no “shortcuts” are being taken regarding vaccine safety.

References

  1. CDC. Coronavirus Disease 2019 (COVID-19): Cases in the US. www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html. Accessed August 18, 2020.
  2. US Department of Health and Human Services. Fact Sheet: explaining Operation Warp Speed. www.hhs.gov/coronavirus/explaining-operation-warp-speed/index.html. Accessed August 18, 2020.
  3. O’Callahan KP, Blatz AM, Offit PA. Developing a SARS-CoV-2 vaccine at warp speed. JAMA. 2020;324:437-438.
  4. Pardi N, Hogan MJ, Porter FW, et al. mRNA vaccines—a new era in vaccinology. Nat Rev Drug Discov. 2018;17:261-279.
  5. Lurie N, Sharfstein JM, Goodman JL. The development of COVID-19 vaccines: safeguards needed [commentary]. JAMA. 2020;324:439-440.
  6. Salman DA, Akhtar A, Mergler MJ, et al; H1N1 Working Group of Federal Immunization Safety Task Force. Immunization safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program. Pediatrics. 2011;127(suppl 1):S78-S86.

,false
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT